Currently Viewing:
AcademyHealth 2019 National Health Policy Conference
Azar Promotes Efforts to Tackle Rebate System
February 04, 2019
Understanding the Health Challenges Facing Rural Communities
February 05, 2019
Currently Reading
Embracing Innovation in Healthcare to Transform Delivery of Care
February 06, 2019
Health Policy in Washington and the States: A Look Ahead
February 06, 2019

Embracing Innovation in Healthcare to Transform Delivery of Care

Jaime Rosenberg
During a session at AcademyHealth National Health Policy Conference held February 4-5 in Washington, DC, healthcare stakeholders discussed 3 innovations that are changing the way we think about healthcare: social determinants of health, digital health, and data.

But even when a patient has a roof over their head, they may still struggle with access to care, explained Naomi Fried, PhD, founder and chief executive officer, Health Innovation Strategies. This is where digital health comes in.

Originally designed to reach people in rural areas without access to clinicians, virtual health has expanded and allowed providers to virtually provide care to people in many situations who struggle with access to a provider.

And virtual health isn’t the only area providing improved access to and quality of care, said Fried. A large part of this innovation is coming from patient-facing digital health solutions, which span across several technologies outside of virtual health.

“Digital health leverages technology to deliver care and information to patients and providers that’s more convenient, cost-effective, and often more personalized,” she explained. “It has potential to decrease costs, improve quality, improve efficiency, and deliver care and information in ways that could not be done before.”

For example, clinical-grade digital information collects information from the patient that is actionable by their provider, who can then make a therapy decision or evaluate a condition. She gave the example of an algorithm created by Massachusetts Institute of Technology researchers that analyzes a person’s typing patterns and determines whether or not they have Parkinson disease. For those who have the disease, the algorithm can track the disease progression.

She also walked through BiliScreen, which uses the iPhone camera to detect pancreatic cancer by recognizing bilibrubin in the whites of the eye. When a person has pancreatic cancer, bilirubin is produced, turning the whites of the eye yellow. However, by the time it’s visible to the human eye, the cancer is typically in advanced stages, so the BiliScreen app allows for much earlier detection.

There is also technology that can change the course of disease after diagnosis, Fried explained. These digiceuticals are digital therapies that utilize software programs to affect clinical outcomes, including a computer program that has been clinically demonstrated to be as effective as drugs for treating multiple sclerosis–linked depression.

However, with promise of these technologies also comes caution, specifically with privacy and security concerns. “At the first level, privacy and security need to be addressed by the developer and they need to be able to assure patients that their information will be used appropriately,” said Fried.

She also pointed to challenges with increasing patient engagement and figuring out ways to reach all patients, as well as address the digital divide, with older generations being less willing to utilize the technology. Choucair added that it’s crucial to ensure these technologies benefit everyone in the community and help close inequities and disparities rather than expand them.

Expressing his excitement for how technology is entering the healthcare industry through analytics, electronic medical records, consumer engagement and more, Chris Coloian, MHA, executive vice president of Cotiviti, said that it’s helping fix a system that is siloed. 

Looking at the role of data on the payment side of things, he said, “How do we de-silo the system, pay for what we intend to create and the value we want, and remove the inefficiencies from the system so we can afford to do it?”

Currently, for payment models, there is a focus on whether care is being delivered for the right diagnosis at the right site of care by the right provider, explained Coloian. Analyzing data coming from CMS and commercial payers, he explained that there’s anywhere from 11% inaccuracy in Medicare to 19% inaccuracy in commercial plans.

Looking forward, he said that using these data will not just address payment accuracy, but also look at the quality of care the patient is receiving.

Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up